ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

KMK Kromek Group Plc

6.80
-0.05 (-0.73%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -0.73% 6.80 6.60 7.00 6.85 6.75 6.85 185,439 11:04:33
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Miscellaneous Metal Ores,nec 17.31M -6.1M -0.0102 -6.67 40.82M
Kromek Group Plc is listed in the Miscellaneous Metal Ores sector of the London Stock Exchange with ticker KMK. The last closing price for Kromek was 6.85p. Over the last year, Kromek shares have traded in a share price range of 3.15p to 8.25p.

Kromek currently has 600,247,000 shares in issue. The market capitalisation of Kromek is £40.82 million. Kromek has a price to earnings ratio (PE ratio) of -6.67.

Kromek Share Discussion Threads

Showing 5276 to 5297 of 7275 messages
Chat Pages: Latest  219  218  217  216  215  214  213  212  211  210  209  208  Older
DateSubjectAuthorDiscuss
10/9/2021
09:38
Morning Andrew

Thank you for your questions and apologies for the slight delay in getting back to you.

In answer to your questions:

How did the biological pathogen detector do in the publicised trials? We have conducted a range of trials and pilots in locations with differing footfall densities and we are now working with those organisations to build and develop appropriate use-case models appropriate for the particular location. The trials went very well and the locations are now evaluating those use-case scenarios and how they might utilise the technology depending on the concentration of Covid or other pathogens present and identified by the technology.
Has the detector been accredited yet by an independent laboratory? The technology has been evaluated by an independent laboratory which determined that it has efficacy equivalent to PCR test standards. However, there is presently no official accreditation standard for measuring airborne pathogen detection so it has not been officially “accredited221;. For information, the equipment will be CE marked when manufactured.
Have any orders been received yet for the detector? We will update the market with commercial progress at the appropriate time.

I hope this helps and thanks for your continued support as a shareholder.

Best regards

Paul

aqc888
10/9/2021
09:37
Some more responses to questions from the AGM I just received from the CFO.

As questions and answers at an AGM are usually public, I don’t deem the email exchange as private.

aqc888
09/9/2021
21:01
Good points Mick, Santa will be here early this year, there`ll be fireworks too
wilsonlough
09/9/2021
14:19
ARK87,
I can see you're a hard man to impress, Kromek a small UK company have developed and built the first Patho Airborne detection prototype and have them in testing off the drawing board (well CAD screen) in January this year....months..
There are to my knowledge a number of US and global companies many times the size and resources of Kromek who have tried and failed to crack this much needed design detection solution...it's an all UK tech world's first if you Weren't aware.

The core RNA sequencing tech being used here was deemed almost impossible only a few years ago, 5 years latter £200 mil spent in development and today they're in the news again one of the UK's true success stories.

My first old engineering boss's favourite saying was -

'The Impossible We Can Do at Once, Miracles Take a Little Longer'

He worked on the design of Concorde and knew his stuff.

Kromek are just about to showcase the system at a London Defence exhibition next week not bad going in my book.

33mick
09/9/2021
14:04
Ark87, they are still within the timeframe reported in the IC it’s easy to forget with all the impatience by myself and others on here. The article 2months ago said expect news in the coming months. Also the article was reporting on the covid detector which as responses to Nicks emails from the CFO seem to suggest that’s still on track. Who knows what’s going on with it... hopefully we get a bit of news next week at the dsei exhibition. If it gets a little media attention we could see another sugar rush spiral upwards while we await the trial results. A small release of new news or regurgitated old news could see that.
aqc888
09/9/2021
12:56
AQC888 - The length of time Covid detector is taking makes me believe they are surely have issues with it? It probably works but maybe not well enough to make it worthwhile hence endless amounts of tweaking? Why else could this be taking so long when under big pressure to get it out?
ark87
09/9/2021
11:15
Someone talking....
dexter1612
09/9/2021
11:11
I note there was no shareholder revolt at the AGM.
Turnover was 35pc ish which is quite high given the current KMK shareholder base.
I could not find the link to the notice and assume that resolution 1 which attracted a 10pc no vote was the approval of the accounts.

cerrito
09/9/2021
10:49
14th September is the before mentioned exhibition at excel. Where the theme of the show is relevant to the detector. I wouldn’t want to sell out now with details that could be released then. Remember there will be buyers of the machine there - if they have any details it would be a good time to release them.
aqc888
09/9/2021
10:41
Could well do, strategicinvestor. Its the same old, same old. Promises, promises.
b00mb0y
09/9/2021
10:33
Could drift back to 15p due to impatience for news later that financial year ?? Thought ?
strategicinvestor2
09/9/2021
10:15
Hopefully you can see this. Your a tit. I'll filter you now.
dexter1612
09/9/2021
09:30
Come on, rampers. This stock is teetering on the cliffs. I’ve got big steaks in this. Do your job and get this share price going north.
b00mb0y
09/9/2021
08:17
@dixter
Are you gambling on the coulds?'

It's the stock market, that's what you do.
Yeah, your right, you were better when filtered.

So you unfiltered me. You obviously find me interesting then. Haha. If not, then just filter me again. Bye.

b00mb0y
09/9/2021
07:58
Quepassa, so what’s your interest in Kromek? I’m guessing you’ve lost a chunk of money in Kromek from the early days and a little bit bitter about it all?
aqc888
09/9/2021
07:08
oh I do apologise if you feel my posts are lacking substance.

I hope this one of mine from earlier this year on 6th April 2021 (post 4244) helps rectify the situation. Perhaps you weren't on the board at the time or missed it.





"Using figures from Equity Development (7/10/20), this is Kromek's seven year performance.

Rounded by me to nearest half-million.


1. TURNOVER FIGURES.

2014 £6m
2015 £8m
2016 £8.5m
2017 £9m
2018 £12m
2019 £14.5m
2020 £13m


These TURNOVER figures include PRODUCT and OTHER.

I assume (but am not certain) that OTHER includes/means grants and research funding. For example, in 2016 OTHER was £3m. In 2019 OTHER was £2.5m



TURNOVER total for last 7 years is £71 million.


2. PROFIT BEFORE TAX - ADJUSTED

2014 -£4.5m LOSS
2015 -£3m LOSS
2016 -£4m LOSS
2017 -£4m LOSS
2018 -£2.5m LOSS
2019 -£1.5m LOSS
2020 -£4m LOSS


LOSS BEFORE TAX (ADJUSTED) for last seven years is £23.5 million.


3. EQUITY RAISING SINCE IPO

30/7/15 £11million
25/1/17 £21million
12/2/19 £21million
12/2/21 £13million


They had raised £53m by end 2020. And the new 2021 Placing, brings total to £66m.

A great deal of shareholder dilution.


4.

SUMMARY. SEVEN YEARS

TURNOVER £71m
LOSS £23.5m
EQUITY RAISINGS £53m (+ another £13m in 2021)



Where does so much money go?

With so many positive messages and so many sure-fire guaranteed, copper-bottomed, game-changer, cutting-edge, state-of-the-art and innovative whizzbang new product initiatives, mostly announced to piggy-back off the latest global scare (nuclear detection, airport security, medical imaging, ventilators ,covid), why does this company still make such resolute losses?


The Easter weekend marked the 7th. anniversary of the infamous 4/4/14 RNS announcement of the seven year up to $159million CZT-based detection modules contract in China.



You see, if you add together ALL Kromek's TURNOVER for the last seven years, the whole lot doesn't come anywhere close to what that ONE SINGLE CONTRACT was meant to bring in.

ALL IMO. DYOR.
QP

"



ALL IMO. DYOR.
QP

quepassa
09/9/2021
06:53
Need to remember that in China, Australia etc they are still closing down areas when a covid case is identified. Big market. Very different approach to U.K. we should remember U.K. is taking an approach which is very different to a lot of other countries.

Also we need to remember that variants seem to be evading the vaccines and that should a new worse variant pop up the machine will be of huge importance.

There will also be niche areas where there detector would be very useful. When a niche area is identified and sold to globally sales will boom. If elderly are found to be vulnerable for example. At £20k per machine it’s not out of the range of many institutions buying just to reassure staff, students, residents etc.

Then there are the sales to governments who are interested in testing cases in the community. Remember the ONS study at the moment is visiting over 100,000 households monthly paying each resident of that house £25 each for swab samples at a cost of well over £10m per month. So governments are still very interested in monitoring the virus in the community. I can envisage many uses for the machine.

People also forget future products Kromek scientists can develop. Something which would be well priced into the share price on a Nasdaq listing

aqc888
09/9/2021
06:32
'Are you gambling on the coulds?'It's the stock market, that's what you do.Yeah, your right, you were better when filtered.
dexter1612
09/9/2021
00:43
The longer the wait the less optimistic i am the covid detector will generate significant revenues. If it was knocking it out the park surely they would have it out by now considering the world is crying out for something like this.
ark87
08/9/2021
21:27
Boomboy, we’re both overly exposed to Kromek, i think I remember you saying Kromek were 40% of your portfolio. It’s 10% of mine currently and showing a 25% profit. I’d generally think it’s unwise holding so much in a single AIM company. I’m nervously keeping a close eye on Kromek. Disappointed there was no news today on the trial results. Hopefully some details will be released when they show the detector at the Excel exhibition on the 14th next week.... I suspect the CFO was taking a more reserved under promise over deliver approach when giving his timescale of the end of this financial year for detector results. The CEO just seems a disaster causing false hope constantly. Partly why there is such little confidence in Kromek
aqc888
08/9/2021
21:07
Retirementfund. Is that all you have to say to answer QuePassa’s detailed blog. Log off pal and go back o bed.
b00mb0y
08/9/2021
21:07
It’s pretty normal quepassa for a company developing a lot of new class leading products not to be profitable. The various products they have developed so far will produce a small profit this financial year. Meanwhile on the side they have developed the biological pathogen detector whilst generating that small profit for the year. Here are some other facts...

Order book covers 75 per cent of revenue estimates for 2021/22 financial year.

£20m worth of nuclear sector revenue in active procurement that could be delivered this year.

Estimated turnover of £15m this year.

House broker Cenkos Securities expects gross margins to rise from 48 to 52 per cent, so with the benefit of a relatively fixed cost base last year’s Covid-19 impacted cash loss of £1.7m is forecast to produce a small adjusted cash profit.

Hill at Equity Development values the annual global market for the biological threat detection devices at £500m.

aqc888
Chat Pages: Latest  219  218  217  216  215  214  213  212  211  210  209  208  Older

Your Recent History

Delayed Upgrade Clock